ArticleCells2021

Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation.

Julian Friebel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.